Neil Kurtz, M.D.

Neil M. Kurtz, M.D. is President and Chief Executive Officer of the Golden Living family of companies.

Prior to joining the company in 2008, he was President and Chief Executive Officer and a member of the Board of Directors of TorreyPines Therapeutics, Inc. Dr. Kurtz took the company public in 2004. The company was purchased by Raptor Pharmaceuticals in 2008. Before that, Dr. Kurtz co-founded Worldwide Clinical Trials, a contract research organization, where he held the positions of President and Chief Executive Officer until its acquisition by United Health Group (UHG) in September 1999. After the acquisition, Dr. Kurtz became President of Ingenix Pharmaceutical Services, a division of UHG, and also served as a member of the UHG Executive Board until joining TorreyPines. Ingenix’ name was changed a few years ago to Optum. Dr. Kurtz’s career also includes senior positions in Research and Development with Boots Pharmaceuticals, Bayer Corporation, Bristol-Myers Squibb, and Merck.

Dr. Kurtz currently serves on the Board of Directors of Medidata Solutions, a global provider of data management services; and TeamHealth, the nation’s leading provider of emergency department services. Dr. Kurtz also has served as a consultant to more than a dozen pharmaceutical companies.

Dr. Kurtz was a member of the faculty in the Department of Psychiatry at the University of Connecticut from 1984 to 1988 and at the University of California, Los Angeles, from July 1980 to 1981. He earned a Bachelor of Arts Degree in Psychology from New York University and a Medical Doctorate Degree from the Medical College of Wisconsin, Milwaukee.